[go: up one dir, main page]

SE408897B - Ostra -1,3,5(10)-trien-derivat till anvendning som mellanprodukter for framstellning av alkoxilerade steroider - Google Patents

Ostra -1,3,5(10)-trien-derivat till anvendning som mellanprodukter for framstellning av alkoxilerade steroider

Info

Publication number
SE408897B
SE408897B SE7508398A SE7508398A SE408897B SE 408897 B SE408897 B SE 408897B SE 7508398 A SE7508398 A SE 7508398A SE 7508398 A SE7508398 A SE 7508398A SE 408897 B SE408897 B SE 408897B
Authority
SE
Sweden
Prior art keywords
alcoxilated
ostra
trien
steroids
manufacture
Prior art date
Application number
SE7508398A
Other languages
English (en)
Other versions
SE7508398L (sv
Inventor
A Pierdet
C Bonne
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7508398L publication Critical patent/SE7508398L/sv
Publication of SE408897B publication Critical patent/SE408897B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
SE7508398A 1971-06-07 1975-07-23 Ostra -1,3,5(10)-trien-derivat till anvendning som mellanprodukter for framstellning av alkoxilerade steroider SE408897B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7120453A FR2140258B1 (sv) 1971-06-07 1971-06-07

Publications (2)

Publication Number Publication Date
SE7508398L SE7508398L (sv) 1975-07-23
SE408897B true SE408897B (sv) 1979-07-16

Family

ID=9078177

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7207425A SE389500B (sv) 1971-06-07 1972-06-06 Sett att framstella 1 11-stellning alkoxilerade steroider tillhorande ostranserien
SE7508398A SE408897B (sv) 1971-06-07 1975-07-23 Ostra -1,3,5(10)-trien-derivat till anvendning som mellanprodukter for framstellning av alkoxilerade steroider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7207425A SE389500B (sv) 1971-06-07 1972-06-06 Sett att framstella 1 11-stellning alkoxilerade steroider tillhorande ostranserien

Country Status (12)

Country Link
US (1) US3818056A (sv)
JP (1) JPS5749560B1 (sv)
BE (1) BE784461A (sv)
CA (2) CA971559A (sv)
CH (1) CH554324A (sv)
DE (1) DE2227492B2 (sv)
DK (1) DK131473B (sv)
FR (1) FR2140258B1 (sv)
GB (2) GB1389945A (sv)
IL (3) IL48282A (sv)
NL (1) NL174047C (sv)
SE (2) SE389500B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502635A (en) * 1974-02-27 1978-03-01 Schering Ag Process for splitting steroid ethers
GB8423017D0 (en) * 1984-09-12 1984-10-17 Plessey Co Plc Echo canceller

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2885413A (en) * 1956-12-17 1959-05-05 Upjohn Co 11-oxygenated estradiol compounds and derivatives
FR5519M (sv) * 1966-06-07 1967-11-06

Also Published As

Publication number Publication date
BE784461A (fr) 1972-12-06
IL39582A (en) 1978-07-31
SE7508398L (sv) 1975-07-23
NL174047B (nl) 1983-11-16
IL48282A0 (en) 1975-12-31
US3818056A (en) 1974-06-18
DK131473C (sv) 1975-12-08
IL39582A0 (en) 1972-07-26
IL48282A (en) 1978-07-31
GB1389945A (en) 1975-04-09
DE2227492B2 (de) 1980-02-28
DE2227492A1 (de) 1972-12-28
GB1390175A (en) 1975-04-09
NL174047C (nl) 1984-04-16
SE389500B (sv) 1976-11-08
DE2227492C3 (sv) 1980-10-16
FR2140258B1 (sv) 1974-08-23
CA971559A (en) 1975-07-22
DK131473B (da) 1975-07-21
NL7207675A (sv) 1972-12-11
JPS5749560B1 (sv) 1982-10-22
CH554324A (fr) 1974-09-30
FR2140258A1 (sv) 1973-01-19
CA993862A (fr) 1976-07-27

Similar Documents

Publication Publication Date Title
SE390414B (sv) 14,15-dioxo-e-homo-eburnaner som mellanprodukt for framstellning av vinkamin
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
NO138167C (no) Fremgangsmaate til fremstilling av et oralt hurtigvirkende stabilt koronarmiddel.
SE389331B (sv) Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
SE403286B (sv) Mellanprodukter for framstellning av 1,4-hydroximorfinanderivat
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
SE409708B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner
FI49503C (sv) Analogiförfarande för framställning av 1,2,3,4-tetrahydro-4-fenyl-isok inolinderivat.
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
BG19375A3 (bg) Метод за получаване на 3,4-1н-изохиномин-1-они
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE413506B (sv) 2,4-diaminopyrimidinforeningar till anvendning som utgangsmaterial for framstellning av 2,4-diamino-5-bensylpyrimidiner
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE408897B (sv) Ostra -1,3,5(10)-trien-derivat till anvendning som mellanprodukter for framstellning av alkoxilerade steroider
CA960698A (en) Process for the manufacture of 1,1,2,2-tetrahydro-perfluoro-alkanols
NO136046C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner.
SE389333B (sv) Forfarande for framstellning av ackalipolyfosfatkomplex av x-6-desoxi-5-hydroxitetsacyklin.
SE409210B (sv) 3,5-dioxo-4,5-seko-gona-9,11-diener till anvendning som mellanprodukter for framstellning av trien-steroidderivat
SE402294B (sv) Desa-9beta-steroider som mellanprodukter till anvendning for framstellning av 9beta, 10alfa-steroider
SE398878B (sv) Forfarande for framstellning av substituerade 2,4-diamino-5-bensylpyrimidiner
SE427180B (sv) 3,7-dimetyl-3-hydroxi-6-oktennitril till anvendning som mellanprodukt for framstellning av lagalkylestrar derav, som er doftemnen
SE389103B (sv) Forfarande for framstellning av 1,4-metano-och 1,4-etanotetrahydro